MXPA03010053A - Vacuna de microplasma inactivada con saponina. - Google Patents

Vacuna de microplasma inactivada con saponina.

Info

Publication number
MXPA03010053A
MXPA03010053A MXPA03010053A MXPA03010053A MXPA03010053A MX PA03010053 A MXPA03010053 A MX PA03010053A MX PA03010053 A MXPA03010053 A MX PA03010053A MX PA03010053 A MXPA03010053 A MX PA03010053A MX PA03010053 A MXPA03010053 A MX PA03010053A
Authority
MX
Mexico
Prior art keywords
saponin
mycoplasma
inactivated mycoplasma
mycoplasma vaccine
inactivated
Prior art date
Application number
MXPA03010053A
Other languages
English (en)
Inventor
Robin Ashley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MXPA03010053A publication Critical patent/MXPA03010053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe una cepa de Mycoplasma que es un agente causante de neumonias bovinas, que se han inactivado mediante su tratamiento con un agente, el Cual altera las membranas celulares, tal como saponina. De preferencia, la cepa es Mycoplasma bovis o Mycoplasma mycoides subespecie mycoides SC. Estas cepas pueden utilizarse como vacunas. Tambien se describen y reivindican composiciones veterinarias, metodos para su preparacion, y su uso en profilaxis.
MXPA03010053A 2001-05-03 2002-05-03 Vacuna de microplasma inactivada con saponina. MXPA03010053A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0110851.3A GB0110851D0 (en) 2001-05-03 2001-05-03 Vaccine
PCT/GB2002/002062 WO2002089838A1 (en) 2001-05-03 2002-05-03 Saponin inactivated mycoplasma vaccine

Publications (1)

Publication Number Publication Date
MXPA03010053A true MXPA03010053A (es) 2004-03-09

Family

ID=9913953

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03010053A MXPA03010053A (es) 2001-05-03 2002-05-03 Vacuna de microplasma inactivada con saponina.

Country Status (12)

Country Link
US (1) US20040170652A1 (es)
EP (1) EP1387693B1 (es)
AT (1) ATE335505T1 (es)
CA (1) CA2445997A1 (es)
CY (1) CY1107538T1 (es)
DE (1) DE60213785T2 (es)
DK (1) DK1387693T3 (es)
ES (1) ES2269672T3 (es)
GB (1) GB0110851D0 (es)
MX (1) MXPA03010053A (es)
PT (1) PT1387693E (es)
WO (1) WO2002089838A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US20070009545A1 (en) * 2005-07-07 2007-01-11 Joachim Frey Mycoplasma subunit vaccine
CN101721694B (zh) * 2009-11-07 2013-01-30 中国农业科学院兰州兽医研究所 山羊支原体肺炎二联灭活疫苗及其制备方法
SI3334454T1 (sl) 2015-08-14 2023-02-28 Zoetis Services Llc Sestave mycoplasma bovis
CN110551653A (zh) * 2019-09-04 2019-12-10 中国农业科学院兰州兽医研究所 一种无血清制备牛支原体抗原的方法
CN110551634A (zh) * 2019-09-04 2019-12-10 中国农业科学院兰州兽医研究所 一种山羊支原体山羊肺炎亚种分离培养方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5540568B2 (es) * 1972-10-05 1980-10-18
GB9108682D0 (en) * 1991-04-23 1991-06-12 Wellcome Found Production of vaccines
WO1995022314A1 (en) * 1994-02-18 1995-08-24 Innovac Co. Inoculation of animals with dried, pelleted biological materials
EP1229929A2 (en) * 1999-11-08 2002-08-14 Biomune VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
PT1387693E (pt) 2006-12-29
EP1387693B1 (en) 2006-08-09
WO2002089838A1 (en) 2002-11-14
EP1387693A1 (en) 2004-02-11
CA2445997A1 (en) 2002-11-14
US20040170652A1 (en) 2004-09-02
GB0110851D0 (en) 2001-06-27
DE60213785D1 (de) 2006-09-21
ATE335505T1 (de) 2006-09-15
ES2269672T3 (es) 2007-04-01
CY1107538T1 (el) 2013-03-13
DE60213785T2 (de) 2007-08-23
DK1387693T3 (da) 2006-11-13

Similar Documents

Publication Publication Date Title
PH12021550318A1 (en) Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PH12017501898A1 (en) Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
MY192183A (en) Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
MX2019008564A (es) Composiciones inmunogenicas para su uso en vacunas neumococicas.
BR112018007812A2 (pt) polissacarídeo capsular, processo para preparar um polissacarídeo capsular e para fabricar uma vacina, composição imunogênica, vacina, métodos para tratamento ou prevenção de uma infecção, para imunizar um hospedeiro humano e para induzir uma resposta imune, e, uso de uma composição imunogênica.
AR041880A1 (es) Composicion inmunogena
MY149604A (en) C.perfringens alpha toxoid vaccine
MX342443B (es) Vacunas que comprenden cepas de mycoplasma bovis atenuadas y metodo para la atenuacion.
IL154913A0 (en) Composition comprising immunogenic microparticles
EP2759307A3 (en) Vaccine against Streptococci
NZ591950A (en) Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
MX2020008454A (es) Composicion inmunogenica que comprende antigenos estafilococicos.
UA98506C2 (en) Attenuated mycoplasma gallisepticum strains
PH12021550484A1 (en) Immunological adjuvant and vaccine composition including sting agonist
GB0110851D0 (en) Vaccine
WO2020102717A3 (en) Clostridium difficile multi-component vaccine
MX2018012270A (es) Novedosas formulaciones de vacuna neumococica.
AU5355801A (en) Recombinant intracellular pathogen vaccines and methods for use
MX2021015155A (es) Polisacaridos de ramnosa.
AR010568A1 (es) Polipeptido, composicion de vacuna, uso del polipeptido en la fabricacion de una composicion, y metodo para producir en un mamifero una respuestainmuno-protectora contra la infeccion de helicobacter pylori
AU6761301A (en) Adjuvant composition comprising fha protein or fragment of fha protein in free form
MX2022001937A (es) Composicion inmunogenica.
MX2022015860A (es) Inmunizacion bacteriana que utiliza una vacuna con nanoparticulas.
UA132124U (uk) Вакцина проти лептоспірозу м'ясоїдних бівалентна
MX2022000525A (es) Vacunas contra la ehrlichia y composiciones inmunogenicas.

Legal Events

Date Code Title Description
FG Grant or registration